CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
CD44 Expression Predicts Prognosis of Ovarian Cancer Patients Through Promoting Epithelial-Mesenchymal Transition (EMT) by Regulating Snail, ZEB1, and Caveolin-1
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 9, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2019-08-22
DOI
10.3389/fonc.2019.00802
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Epithelial-Mesenchymal Plasticity in Cancer Progression and Metastasis
- (2019) Wei Lu et al. DEVELOPMENTAL CELL
- Human epithelial ovarian cancer cells expressing CD105, CD44 and CD106 surface markers exhibit increased invasive capacity and drug resistance
- (2019) Jin Zhang et al. Oncology Letters
- APOBEC3B up-regulation independently predicts ovarian cancer prognosis: a cohort study
- (2018) Yan Du et al. Cancer Cell International
- Mesenchymal splice isoform of CD44 (CD44s) promotes EMT/invasion and imparts stem-like properties to ovarian cancer cells
- (2018) Rahul Bhattacharya et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition
- (2017) Ramkrishna Mitra et al. Nature Communications
- Cancer statistics in China, 2015
- (2016) Wanqing Chen et al. CA-A CANCER JOURNAL FOR CLINICIANS
- EMT: 2016
- (2016) M. Angela Nieto et al. CELL
- Clinical relevance of CD44 surface expression in advanced stage serous epithelial ovarian cancer: a prospective study
- (2016) Alaa A. Elzarkaa et al. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY
- The Importance of CD44 as a Stem Cell Biomarker and Therapeutic Target in Cancer
- (2016) Ranjeeta Thapa et al. Stem Cells International
- CD44 expression contributes to trastuzumab resistance in HER2-positive breast cancer cells
- (2015) Delphine R. Boulbes et al. BREAST CANCER RESEARCH AND TREATMENT
- CD44 variant 6 is correlated with peritoneal dissemination and poor prognosis in patients with advanced epithelial ovarian cancer
- (2015) Francisca Tjhay et al. CANCER SCIENCE
- Expression and Significance of CD44, CD47 and c-met in Ovarian Clear Cell Carcinoma
- (2015) Huimin Wang et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Caveolin-1 Limits the Contribution of BKCa Channel to MCF-7 Breast Cancer Cell Proliferation and Invasion
- (2014) Cheng Du et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Correlation of CD44v6 expression with ovarian cancer progression and recurrence
- (2013) Jun Shi et al. BMC CANCER
- A potential anti-tumor herbal medicine, Corilagin, inhibits ovarian cancer cell growth through blocking the TGF-β signaling pathways
- (2013) Luoqi Jia et al. BMC Complementary and Alternative Medicine
- Caveolin-1 as a promoter of tumour spreading: when, how, where and why
- (2013) Rebecca Senetta et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Evidence of a role for CD44 and cell adhesion in mediating resistance to lenalidomide in multiple myeloma: therapeutic implications
- (2013) C C Bjorklund et al. LEUKEMIA
- Hormone Therapy and Different Ovarian Cancers: A National Cohort Study
- (2012) L. S. Morch et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- Overexpression of CD44 accompanies acquired tamoxifen resistance in MCF7 cells and augments their sensitivity to the stromal factors, heregulin and hyaluronan
- (2012) Stephen Hiscox et al. BMC CANCER
- Ovarian Cancer
- (2012) JESSICA HUNN et al. CLINICAL OBSTETRICS AND GYNECOLOGY
- Inhibition of ZEB1 reverses EMT and chemoresistance in docetaxel-resistant human lung adenocarcinoma cell line
- (2012) Jin Ren et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- CXCL12/CXCR4 Axis Triggers the Activation of EGF Receptor and ERK Signaling Pathway in CsA-Induced Proliferation of Human Trophoblast Cells
- (2012) Hong-Bo Zhao et al. PLoS One
- Targeting the Mechanisms of Resistance to Chemotherapy and Radiotherapy with the Cancer Stem Cell Hypothesis
- (2010) Ryan Morrison et al. Journal of Oncology
- Epithelial–mesenchymal transition in tumor metastasis: a method to the madness
- (2009) Venkateshwar G Keshamouni et al. Future Oncology
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
- (2009) Shigeo Takaishi et al. STEM CELLS
- CD44 is of Functional Importance for Colorectal Cancer Stem Cells
- (2008) L. Du et al. CLINICAL CANCER RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started